Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant IB. subtilis/I on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate

Various types of vaccines, such as mRNA, adenovirus, and inactivated virus by injection, have been developed to prevent SARS-CoV-2 infection. Although some of them have already been approved under the COVID-19 pandemic, various drawbacks, including severe side effects and the requirement for sub-zer...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Vaccines (Basel) 2021-12, Vol.10 (1)
Hauptverfasser:	Sung, Johnny Chun-Chau, Liu, Ying, Wu, Kam-Chau, Choi, Man-Chung, Ma, Chloe Ho-Yi, Lin, Jayman, He, Emily Isabel Cheng, Leung, David Yiu-Ming, Sze, Eric Tung-Po, Hamied, Yusuf Khwaja, Lam, Dominic Man-Kit, Kwong, Keith Wai-Yeung
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Bacillus subtilis Oral vaccines Product development Properties Protein binding
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!